Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Depreciation and Depletion: 2021-2022

Historic Depreciation and Depletion for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $25,582.

  • Cardiol Therapeutics' Depreciation and Depletion fell 6.60% to $25,582 in Q3 2022 from the same period last year, while for Sep 2022 it was $111,067, marking a year-over-year change of. This contributed to the annual value of $118,877 for FY2024, which is 2.15% down from last year.
  • According to the latest figures from Q3 2022, Cardiol Therapeutics' Depreciation and Depletion is $25,582, which was down 0.16% from $25,623 recorded in Q2 2022.
  • Cardiol Therapeutics' Depreciation and Depletion's 5-year high stood at $33,509 during Q2 2021, with a 5-year trough of $25,582 in Q3 2022.
  • In the last 2 years, Cardiol Therapeutics' Depreciation and Depletion had a median value of $27,353 in 2021 and averaged $28,349.
  • Over the last 5 years, Cardiol Therapeutics' Depreciation and Depletion had its largest YoY gain of 22.79% in 2022, and its largest YoY loss of 23.53% in 2022.
  • Cardiol Therapeutics' Depreciation and Depletion (Quarterly) stood at $27,353 in 2021, then decreased by 6.60% to $25,582 in 2022.
  • Its last three reported values are $25,582 in Q3 2022, $25,623 for Q2 2022, and $32,509 during Q1 2022.